Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
OFEV, VARGATEF (Boehringer Ingelheim Pty Ltd)
Product name
OFEV, VARGATEF
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
223 (255 working days)
Active ingredients
nintedanib esilate
Registration type
EOI
Indication
OFEV, VARGATEF (soft capsule) are now also indicated for the treatment of other chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype.